Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Zone Specific AIM

K-Number: K220186 · 2022-05-13

Decision Date2022-05-13
Product CodeGAT
Advisory CommitteeSU
DecisionSubstantially Equivalent

Device Summary

Zone Specific AIM is a medical device manufactured by Conmed Corporation. It received FDA 510(k) clearance on 2022-05-13 under approval number K220186. The device is classified under product code GAT. It was reviewed by the SU advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Zone Specific AIM?

Zone Specific AIM is a medical device that received FDA 510(k) clearance on 2022-05-13. It is manufactured by Conmed Corporation. The 510(k) number is K220186.

When was Zone Specific AIM approved by the FDA?

Zone Specific AIM received FDA 510(k) clearance on 2022-05-13, under approval number K220186.

What company makes Zone Specific AIM?

Zone Specific AIM is manufactured by Conmed Corporation.

What is the FDA product code for Zone Specific AIM?

The FDA product code for Zone Specific AIM is GAT.

Other Devices by Conmed Corporation

View all 47 devices →

Related Devices (Code: GAT)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.